Prostate News Archive
15-Mar-2011
Prostate cancer tests improve with technology
When 54-year-old Jeff Rolf went in for his annual physical three years ago, he did not expect to come away with news of an abnormal PSA level and, eventually, a prostate cancer diagnosis. Prostate Cancer Tests Improving
prostate cancer tests may be improving, thanks to a new screening method giving more specific results. The new test has recently been submitted to the Food and Drug Administration for approval. prostate cancer has long been detected by screening levels of prostate-specific antigen (PSA). An increased PSA level indicates necessity for further testing, usually in the form of a biopsy. High... Statin Use Reduces Risk of Prostate Cancer
ORLANDO, Fla., March 14, 2011 /PRNewswire/ -- Men who take a certain class of cholesterol-lowering medicine, otherwise known as statins, may be 60 percent less likely to be diagnosed with high-grade prostate cancer. Some of the results of this powerful study involving more than 55,000 men were discussed at the Prostate Cancer Research Program's (PCRP's) Innovative Minds in Prostate Cancer Today ... Prostate Cancer: Clinical Trial to Use Diet to Treat Patients
Prostate cancer researchers are working on a new clinical trial that will seek to use diet to help treat the cancer and prevent it from progressing. Research Shows Rapid Adoption Of Newer, More Expensive Prostate Cancer Treatments
With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in the country. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States. New research from the Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) shows that newer, more expensive treatment options ...
Back to Prostate News Archive
